The ABNL-MARRO 001 study: a phase 1–2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes

BACKGROUND: Myelodysplastic/myeloproliferative neoplasms (MDS/MPN) comprise several rare hematologic malignancies with shared concomitant dysplastic and proliferative clinicopathologic features of bone marrow failure and propensity of acute leukemic transformation, and have significant impact on pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Moyo, Tamara K., Mendler, Jason H., Itzykson, Raphael, Kishtagari, Ashwin, Solary, Eric, Seegmiller, Adam C., Gerds, Aaron T., Ayers, Gregory D., Dezern, Amy E., Nazha, Aziz, Valent, Peter, van de Loosdrecht, Arjan A., Onida, Francesco, Pleyer, Lisa, Cirici, Blanca Xicoy, Tibes, Raoul, Geissler, Klaus, Komrokji, Rami S., Zhang, Jing, Germing, Ulrich, Steensma, David P., Wiseman, Daniel H., Pfeilstöecker, Michael, Elena, Chiara, Cross, Nicholas C. P., Kiladjian, Jean-Jacques, Luebbert, Michael, Mesa, Ruben A., Montalban-Bravo, Guillermo, Sanz, Guillermo F., Platzbecker, Uwe, Patnaik, Mrinal M., Padron, Eric, Santini, Valeria, Fenaux, Pierre, Savona, Michael R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509596/
https://www.ncbi.nlm.nih.gov/pubmed/36153475
http://dx.doi.org/10.1186/s12885-022-10073-w

Ejemplares similares

Ejemplares similares